Natural Killer cells as COVID-19 therapy [electronic resource] / an interview with Pippa Kennedy.
Material type:
SoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2020Description: 1 online resource (1 streaming audio file (14 min.))Subject(s): Clinical trials | COVID-19 (Disease) -- Treatment | Killer cells -- Therapeutic use | Natural immunity | Clinical Trials, Phase I as Topic | Coronavirus Infections -- drug therapy | Coronavirus Infections -- immunology | COVID-19 -- therapy | Induced Pluripotent Stem Cells | Killer Cells, Natural -- drug effects | Killer Cells, Natural -- immunology | Pneumonia, Viral -- drug therapy | Pneumonia, Viral -- immunology | SARS-CoV-2 | Virus Diseases -- immunologyOnline resources: Click here to access online | Series Audio interview.
Title from title frames.
Contents: The role of Natural Killer (NK) cells in viral infections -- Why NK cells are being investigated -- Induced pluripotent stem cell derived natural killer cells for SARS-CoV-2 therapy -- Benefits of this therapy -- Current stage of the clinical trial.
Access restricted to subscribers.
Mode of access: World Wide Web.